Catabasis Pharmaceuticals Inc (NASDAQ:CATB)

0.82
Delayed Data
As of Jul 16
 -0.03 / -3.53%
Today’s Change
0.78
Today|||52-Week Range
3.78
-44.97%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Catabasis Pharmaceuticals Inc have a median target of 6.00, with a high estimate of 7.00 and a low estimate of 2.50. The median estimate represents a +631.71% increase from the last price of 0.82.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Catabasis Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.23
Sales
$0.00
Reporting Date
Aug 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 21.67%
 
 
 
 
 
 
Growthannually 30.18%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually -100.00%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.